Multiethnic myeloma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore.Bone marrow transplantation · 2017
   Trial
2. Disparities in Outcomes of Hospitalizations Due to Multiple Myeloma: A Nationwide Comparison.Cureus · 2023
   Article
3. Multiple myeloma, race, insurance and treatment.Cancer epidemiology · 2021
   Article
4. Epidemiology, Staging, and Management of Multiple Myeloma.Medical sciences (Basel, Switzerland) · 2021
   Review
5. Multiple myeloma epidemiology and survival: A unique malignancy.Seminars in oncology · 2016
   Review
6. Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells.American journal of cancer research · 2015
   Article

Corrections and comments

• Comment on
  Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.2013

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as